Cargando…
Interferon gamma in cancer immunotherapy
Immune system can recognize self vs transformed self. That is why cancer immunotherapy achieves notable benefits in a wide variety of cancers. Recently, several papers reported that immune checkpoint blockade therapy led to upregulation of IFNγ and in turn clearance of tumor cells. In this review, w...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6143921/ https://www.ncbi.nlm.nih.gov/pubmed/30039553 http://dx.doi.org/10.1002/cam4.1700 |
_version_ | 1783356064694009856 |
---|---|
author | Ni, Ling Lu, Jian |
author_facet | Ni, Ling Lu, Jian |
author_sort | Ni, Ling |
collection | PubMed |
description | Immune system can recognize self vs transformed self. That is why cancer immunotherapy achieves notable benefits in a wide variety of cancers. Recently, several papers reported that immune checkpoint blockade therapy led to upregulation of IFNγ and in turn clearance of tumor cells. In this review, we conducted an extensive literature search of recent 5‐year studies about the roles of IFNγ signaling in both tumor immune surveillance and immune evasion. In addition to well‐known functions, IFNγ signaling also induces tumor ischemia and homeostasis program, resulting in tumor clearance and tumor escape, respectively. The yin and the yang of IFNγ signaling are summarized. Thus, this review helps us to comprehensively understand the roles of IFNγ in tumor immunity, which contributes to better design and management of clinical immunotherapy approaches. |
format | Online Article Text |
id | pubmed-6143921 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-61439212018-09-24 Interferon gamma in cancer immunotherapy Ni, Ling Lu, Jian Cancer Med Cancer Biology Immune system can recognize self vs transformed self. That is why cancer immunotherapy achieves notable benefits in a wide variety of cancers. Recently, several papers reported that immune checkpoint blockade therapy led to upregulation of IFNγ and in turn clearance of tumor cells. In this review, we conducted an extensive literature search of recent 5‐year studies about the roles of IFNγ signaling in both tumor immune surveillance and immune evasion. In addition to well‐known functions, IFNγ signaling also induces tumor ischemia and homeostasis program, resulting in tumor clearance and tumor escape, respectively. The yin and the yang of IFNγ signaling are summarized. Thus, this review helps us to comprehensively understand the roles of IFNγ in tumor immunity, which contributes to better design and management of clinical immunotherapy approaches. John Wiley and Sons Inc. 2018-07-23 /pmc/articles/PMC6143921/ /pubmed/30039553 http://dx.doi.org/10.1002/cam4.1700 Text en © 2018 The Authors. Cancer Medicine published by John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Cancer Biology Ni, Ling Lu, Jian Interferon gamma in cancer immunotherapy |
title | Interferon gamma in cancer immunotherapy |
title_full | Interferon gamma in cancer immunotherapy |
title_fullStr | Interferon gamma in cancer immunotherapy |
title_full_unstemmed | Interferon gamma in cancer immunotherapy |
title_short | Interferon gamma in cancer immunotherapy |
title_sort | interferon gamma in cancer immunotherapy |
topic | Cancer Biology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6143921/ https://www.ncbi.nlm.nih.gov/pubmed/30039553 http://dx.doi.org/10.1002/cam4.1700 |
work_keys_str_mv | AT niling interferongammaincancerimmunotherapy AT lujian interferongammaincancerimmunotherapy |